According to a research report titled ‘Cardiac Arrhythmia Monitoring Devices Market Size By Devices, By Application (Tachycardia {Atrial Tachycardia, Ventricular Tachycardia}, Bradycardia, Premature Contractions), By End-use (Hospitals and Clinics, Diagnostics Centers, Ambulatory Surgical Centers, Homecare Settings), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, cardiac arrythmia monitoring devices is projected to record substantial gains during 2020-2026.
 

Report findings state that rising geriatric population, increased prevalence of cardiovascular diseases, and technological advancements in healthcare infrastructure are the primary factors responsible for cardiac arrhythmia monitoring devices market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2144058/
 

Advancements in technologies such as device & electrode design, and on-board analysis are providing optimum diagnostic facilities to patients, thereby enhancing the industry remuneration.
 

For the unversed, arrhythmia monitoring is the testing procedure used for identifying the cause and type of irregular heart rhythms, and to examine the electrical function of the heart. Physicians generally use EP (electrophysiology) to diagnose arrhythmias.
 

Based on application,  cardiac arrhythmia monitoring devices market is classified into premature contractions, tachycardia, and bradycardia. Among these, premature contractions segment recorded over USD 260 million in terms of revenue in 2019 and is expected to generate significant revenues in the ensuing years. Increased risk of cardiomyopathy necessitates constant monitoring, hence, adding traction to segmental growth.
 

By device type, the industry is split into electrocardiogram (ECG) monitor, holter monitor, mobile cardiac telemetry, event recorder, and implantable cardiac monitor. The event recorder egment is anticipated to register an annual growth rate of 7.1% during the forecast period. This can be attributed to new product launches, ease usability, and rising penetration of wearable devices in the market.
 

Moving on to the end-user scope, the market comprises of diagnostics centers, hospitals and clinics, homecare settings and ambulatory surgical centers. Among these, diagnostic centers segment is slated to record 7% CAGR over the analysis timespan. Factors such developing healthcare infrastructure, growing availability of better diagnostic facilities, increasing R&D activities will favor the segmental growth.
 

From a geographical perspective, Europe arrhythmia monitoring devices market is projected to record 7.6% CAGR through 2026, on account of rising awareness heart diagnostics solutions, growing presence of industry players, and elevated risk among the expanding the geriatric populace.
 

Major contenders in cardiac arrhythmia monitoring devices market are Welch Allyn, Inc., Spacelabs Healthcare, Abbott Laboratories, Nihon Kohden Corp., Medtronic plc, Koninklijke Philips N.V., Irhythm Technologies, Inc., GE Healthcare, BioTelemetry, Inc., Biotricity, Inc., Biotronik SE & Co. KG, and AliveCor, Inc.